 |
인쇄하기
취소
|
HS Biopharm acquires Kyungnam Pharm
HS Biopharm, local human placenta manufacturer, said on July 9 that it acquired 100 percent stake of Kyungnam Pharm owned by Green Cross Corporation (GCC) and GCC holding.
An official of HS Biopharm said that for the deal, the company invested 24.5 billion won and the acquisition will make it easier for HS BioPharm to maximize its corporate value in pharmaceutical business.
The merger dea...
An official of HS Biopharm said that for the deal, the company invested 24.5 billion won and the acquisition will make it easier for HS BioPharm to maximize its corporate value in pharmaceutical business.
The merger dea...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.